Skip to main content
. Author manuscript; available in PMC: 2015 Jun 27.
Published in final edited form as: Neurorehabil Neural Repair. 2013 Dec 27;28(5):433–442. doi: 10.1177/1545968313516868

Table 1.

Demographic and clinical stroke characteristics.

Patient Age/Sex Time after stroke (mo) Lesion location Lesion volume (mm3) Fazekas FMUE
1 61/M 24 L / BG, IC, CR 25,339.9 1 10
2 58/M 27 R / PLIC, BG 553.7 1 24
3 59/M 144 L / PLIC, BG 1,451.9 0 25
4 44/F 106 L / BG, IC, CR 17,881.3 0 26
5 56/F 6 R / PLIC, BG 6,902.9 0 29
6 61/M 12 L/Pons 1,445.8 0 30
7 45/M 27 L / BG, CR 180.4 0 36
8 71/M 26 R / PLIC, BG 1,192.7 1 37
9 73/M 60 R / ALIC, BG 21,960.35 0 41
10 65/M 36 R / BG, CR 271.6 1 42
11 61/F 27 L / CP 2357.2 1 50
12 56/M 23 L / ALIC 490.4 1 50
13 46/F 8 R / BG 737.4 1 58
14 54/F 12 L /ALIC/genu, BG 450.0 0 60
15 48/F 11 L / PLIC, BG 60,450.3 0 61
16 46/M 52 L / PLIC, BG 740.0 0 63
17 68/M 63 L / PLIC, T 1,449.3 0 65
18 57/M 6 L / BG, CR 10501.9 1 66

M, male; F, female; mo, months; L, left; R, right; BG, basal ganglia; CR, corona radiata; PLIC, posterior limb internal capsule; ALIC, anterior limb internal capsule; CP, cerebral peduncle; T, thalamus; mm=millimeters; Fazekas scale for white matter hyperintensities FMUE (0 to 3, 0 and 1 normal for elderly), Fugl-Meyer Upper Extremity, normal=66, as recorded at the recruitment into study, Fazekas scale (normal for elderly people=0 and 1).